ABSTRACT
While the proximate driver behind the decline of the Western stock of Steller sea lions (Eumetopias jubatus, >80% since 1970s) is likely multifactorial, the population reduction may have been powered by a decrease in fecundity. A harvest of Steller sea lions in the 1970s and 80s revealed a 30% reduction in the proportion of pregnant females from early (October-November) to late gestation (April-May). Identification and quantification of these reproductive failures are difficult when we lack species-specific data on endocrinology associated with discrete stages of the reproductive cycle (i.e., estrus, implantation, and gestation). We tracked changes in serum estradiol and progesterone in three adult female Steller sea lions from 2011 to 2015. In all years and most females, a discrete increase in estradiol was observed during the breeding season (June-August), indicative of estrus. Estradiol concentrations from October to May in a pregnant female compared to her corresponding values when non-pregnant did not consistently differ through gestation. An elevation in progesterone was observed in all females and all years beginning approximately in June and lasting through November. This likely results from progesterone production by the corpus luteum in both pregnant and pseudopregnant females. Serum progesterone shows promise as a diagnostic tool to identify pregnancy during months 3-5 (December-February) of the 8-month active gestation following embryonic implantation. This study provides ranges of key hormones during estrus, embryonic diapause/pseudopregnancy, and gestation in pregnant and non-pregnant females for studying reproduction in Steller sea lions.
Subject(s)
Estradiol/blood , Estrus/blood , Pregnancy, Animal , Progesterone/blood , Sea Lions/blood , Sea Lions/physiology , Animals , Female , Pregnancy , Pregnancy, Animal/blood , Pseudopregnancy/bloodABSTRACT
The aim of this study was to examine the long-term effect of a 4.7-mg deslorelin GnRH analog implant on ovarian function in the prepubertal female rabbit. Seven female rabbits (group 1) were treated with the implant at the age of 60 days. The implant was inserted subcutaneously in the umbilical region. Two animals (group 2) were not treated and served as a control group. The vulva of all 9 animals was examined for the presence of typical cyclical changes, additionally the occurrence of mounting behavior was recorded. Ovarian function was checked by administration of a short-acting GnRH agonist to induce ovulation and pseudopregnancy (0.8 µg of buserelin per animal intramuscularly). Ten days after each treatment with buserelin, blood was collected for progesterone measurement to confirm pseudopregnancy. After implant insertion, the first blood collection (Day 10) was done without preceding induction of ovulation to screen for implant induced ovulation and pseudopregnancy. The implant was in situ for 273 days, and during this time span, 12 attempts of induction of ovulation were carried out in intervals of 21 days, beginning at the age of 81 days. Afterward, it was removed under local anesthesia and 3 further inductions of ovulation by the same scheme were conducted. The insertion of the implant led to the establishment of a pseudopregnancy in 2 of 7 animals; the remaining 5 animals did not show elevated progesterone values. Attempts to induce ovulation by administration of the short-acting GnRH analog while the slow-release GnRH analog implant was in place were not successful in treated animals, and progesterone concentrations were basal. The effect was reversible as ovulation could be induced in 2 subsequent cycles in all animals by the third induction of ovulation after implant removal. Induction of ovulation in control animals at the age of 110 and 131 days resulted in elevated progesterone levels after 10 days. No adverse side effects could be observed in implant-treated animals. The typical red coloration of the vulva could be seen in group 2 and after implant removal in group 1. The results suggest that in 5 of 7 rabbits, puberty was delayed by the treatment with the 4.7-mg deslorelin slow-release analog until the implant had been removed. In the other animals, the treatment induced an initial flare-up phenomenon. Afterward, the treatment could reversibly suppress ovarian function in all 7 treated animals.
Subject(s)
Estrous Cycle/drug effects , Ovary/drug effects , Rabbits/physiology , Sexual Maturation/drug effects , Triptorelin Pamoate/analogs & derivatives , Animals , Buserelin/administration & dosage , Delayed-Action Preparations , Drug Implants , Female , Gonadotropin-Releasing Hormone/agonists , Ovary/physiology , Ovulation Induction , Progesterone/blood , Pseudopregnancy/blood , Pseudopregnancy/chemically induced , Triptorelin Pamoate/administration & dosageABSTRACT
The corpus luteum is a temporary endocrine structure in mammals that plays an important role in the female reproductive cycle and is formed from a ruptured and ovulated follicle with rapid angiogenesis. Vascular endothelial growth factor (VEGF) is thought to be vital in normal and abnormal angiogenesis in the ovary, but the molecular regulation of luteal VEGF expression during corpus luteum development in vivo is still poorly understood at present. Therefore, we examined whether hypoxia-inducible factor-1a (HIF-1a) is induced and regulates VEGF expression and luteal function in vivo using a pseudopregnant rat model treated with a small-molecule inhibitor of HIF-1a, echinomycin. Corpus luteum development in the pseudopregnant rat ovary was determined after measuring plasma progesterone concentration and ovarian prostaglandin F2a content to reflect changes in HIF-1a and VEGF on different days of this developmental process. At day 7, the corpus luteum was formed and the expression of HIF- 1a/VEGF reached a maximum, while a significant decrease in HIF-1a/ VEGF expression was observed when luteolysis occurred at day 13. Additionally, echinomycin blocked luteal development by inhibiting VEGF expression mediated by HIF-1a and following luteal function by detecting the progesterone changes at day 7. These results demonstrated that HIF-1a-mediated VEGF expression might be an important mechanism regulating ovarian luteal development in mammals in vivo, which may provide new strategies for fertility control and for treating some types of ovarian dysfunction, such as polycystic ovarian syndrome, ovarian hyperstimulation syndrome, and ovarian neoplasia.
Subject(s)
Corpus Luteum/growth & development , Dinoprost/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Ovary/metabolism , Progesterone/blood , Pseudopregnancy/metabolism , Vascular Endothelial Growth Factor A/metabolism , Animals , Corpus Luteum/metabolism , Corpus Luteum Maintenance , Female , Gene Expression Regulation , Male , Pregnancy , Pseudopregnancy/blood , Rats , Rats, Sprague-Dawley , Signal TransductionABSTRACT
The erythrocytic parameters during pregnancy and pseudopregnancy in bitches were studied and compared in 8 bitches aged 2 -3 years and weighing 10-12 kg. Blood samples were collected from the bitches before mating, during the three trimesters of pregnancy and the post partum period. The packed cell volume (PCV %), haemoglobin concentration (Hb gm/dl), red blood cell count(x10(6)/µl) were determined using standard methods. The mean corpuscular volume (MCV) and mean corpuscular haemoglobin concentration (MCHC) were then calculated. Six of the bitches were pregnant and 2 were pseudopregnant. The results showed that in pregnant bitches, the PCV decreased significantly from the premating values of 51.37+0.94% to 34.00+8.04% during the third trimester of pregnancy (P<0.05). There was also a significant decrease in Hb values (P<0.05) from the premating period (16.30 ± 0.20gm/dl) to the third trimester of pregnancy (11.25±1.80gm/dl). The values of Red blood cells (RBCx10(6)/µl) during the premating period (12.70+3.15) were not significantly different from the values during the first second and third trimesters (11.13+3.87, 10.38+4.54 and 12.24+3.15, respectively). The trend of decrease in PCV and Hb values were not observed in the bitches with pseudopregnancy. This shows that these erythrocytic parameters can be used to detect and differentiate between pregnancy and pseudopregnancy in bitches as early as the first 20 days post mating.
Subject(s)
Erythrocyte Indices/veterinary , Erythrocytes/metabolism , Hemoglobins/metabolism , Pregnancy Tests/veterinary , Pseudopregnancy/veterinary , Animals , Biomarkers/blood , Dogs , Erythrocyte Count/veterinary , Female , Hematocrit/veterinary , Nigeria , Predictive Value of Tests , Pseudopregnancy/blood , Pseudopregnancy/diagnosis , Time FactorsABSTRACT
The aims of this study were to determine whether a single treatment of estradiol dipropionate (EDP) could induce pseudopregnancy in gilts and to determine the effectiveness of PGF(2alpha) treatment on estrus synchronization in EDP-induced pseudopregnant gilts. In experiment 1, gilts were treated with 20 mg of EDP (n=11) or vehicle (n=5) on Day 12 (Day 0=onset of estrus). Establishment of pseudopregnancy was defined as a lack of estrus and maintenance of the plasma progesterone concentration above 1 ng/ml between Days 12 and 36. Nine of 11 gilts (82%) treated with EDP became pseudopregnant. The plasma estradiol-17beta level was significantly higher in the EDP-treated gilts than in the control gilts until Day 29. In experiment 2, PGF(2alpha) was administered twice with a 24-h interval from Day 36 in pseudopregnant gilts (n=6) or Day 10 in cyclic gilts (control; n=5). Estrus after PGF(2alpha) treatment was observed in 83% of the pseudopregnant gilts. The interval from the day of the first PGF(2alpha) treatment to the onset of estrus and the peak of the LH surge was significantly shorter in the pseudopregnant gilts than in the control gilts. In experiment 3, six pseudopregnant gilts were bred by artificial insemination at the estrus after PGF(2alpha) treatment. The farrowing rate and average litter size did not differ between the PGF(2alpha)-treated pseudopregnant and cyclic gilts. These results indicate that a single treatment of EDP on Day 12 of the estrous cycle can induce pseudopregnancy in pigs and that a convenient protocol for administering PGF(2alpha) to EDP-induced pseudopregnant pigs is available for estrus synchronization programs in cyclic pigs.
Subject(s)
Estradiol/analogs & derivatives , Estrus Synchronization/methods , Pseudopregnancy , Swine , Animals , Drug Administration Schedule , Estradiol/administration & dosage , Estradiol/blood , Estrous Cycle/blood , Estrus Synchronization/blood , Female , Fertility Agents, Female/administration & dosage , Follicle Stimulating Hormone/blood , Insemination, Artificial , Litter Size , Luteinizing Hormone/blood , Pregnancy , Pregnancy Rate , Progesterone/blood , Pseudopregnancy/blood , Pseudopregnancy/veterinaryABSTRACT
Progesterone receptor (PR) plays an important role in mammals pregnancy which is characterized by greater progesterone plasma concentrations. We assessed PR protein distribution in the rabbit uterus by immunohistochemistry in two progestational conditions: pseudopregnancy (intact adult animals treated with hCG) and after application of a synthetic progestin, medroxyprogesterone acetate (MPA), to ovariectomized animals (OVX). PR immunoreactivity in uterine epithelium of pseudopregnant rabbits was increased in relation to non-pseudopregnant (NP) rabbits. Amounts were similar on Days 1, 3, and 5 of treatment, and was greater on Day 7 (P<0.001). In contrast, a significant diminution in PR immunoreactivity was observed in stroma cells from Days 1 to 7 (P<0.001). In OVX rabbits treated with MPA, an increase in PR immunoreactivity was observed in the uterine epithelium on Days 1 to 5 of treatment, reaching a maximum on Day 3 (P<0.001). In contrast, in stromal cells a diminution in PR immunoreactivity was observed when compared to the OVX group on Days 1, 3 and 7 of MPA treatment (P<0.001), and there was a slight increase on Day 5. Results suggest a differential time course and tissue specific immunoreactivity for PR in the uterus of the rabbit in two progestational conditions. The present study indicated synthetic progestins have different mechanisms of receptor regulation than those of natural hormones and it should be taken into account in reproductive applications.
Subject(s)
Medroxyprogesterone Acetate/pharmacology , Pseudopregnancy/metabolism , Receptors, Progesterone/metabolism , Uterus/drug effects , Uterus/metabolism , Animals , Chorionic Gonadotropin/pharmacology , Contraceptive Agents/pharmacology , Drug Evaluation, Preclinical , Female , Immunohistochemistry , Ovariectomy , Progesterone/blood , Pseudopregnancy/blood , Pseudopregnancy/pathology , Rabbits , Time Factors , Uterus/pathologyABSTRACT
Plasma concentrations of progesterone (P(4)) and prolactin (PRL) were measured in 35 bitches presented at veterinary clinics for symptoms of overt pseudopregnancy (PSP) between 50 and 95 days after the onset of proestrus. Results were compared to those from samples collected from 35 control bitches at comparable stages of the ovarian cycle (expressed as days after the onset of observed signs of proestrus). In the PSP bitches at 71.4+/-1.6 (mean+/-S.E.M.) days of the cycle, P(4) (1.5+/-0.2ng/mL) was lower (P<0.01) and PRL (16.0+/-1.9ng/mL) was higher (P<0.01), compared to P(4) (2.7+/-0.4ng/mL) and PRL (2.9+/-0.6ng/mL) in control bitches at 70.6+/-1.5 days of the cycle. Low P(4) was not a prerequisite for elevated PRL. Although elevated (> or =10ng/mL) PRL (20.9+/-2.0ng/mL) occurred more often with low (<2ng/mL) P(4) (20 of 24 cases) it also occurred with P(4) above 3ng/mL in two affected bitches and in two control bitches. Whether the occurrence of relatively low PRL concentrations (<4ng/mL) in samples obtained from 4 of the 35 pseudopregnant bitches reflected variable and often elevated PRL secretion or increased sensitivity to PRL in the absence of elevated prolactin in those animals was not determined. We inferred that elevated plasma PRL was often involved in the etiology of overt PSP; furthermore, a premature decline in circulating P(4) concentrations may be a factor in some instances.
Subject(s)
Dog Diseases/blood , Progesterone/blood , Prolactin/blood , Pseudopregnancy/veterinary , Animals , Dogs , Female , Prospective Studies , Pseudopregnancy/bloodABSTRACT
Corpus luteum (CL) formation involves dramatic tissue remodeling and angiogenesis. To determine the functional roles of the plasminogen activator and matrix metalloproteinase (MMP) systems in these processes, we have studied CL formation and function in plasminogen (plg)-deficient mice, with or without treatment with the broad-spectrum synthetic MMP inhibitor galardin. Both the adult pseudopregnant CL model and the gonadotropin-primed immature mouse model were used. We found that CL formed normally not only in plasminogen-deficient mice and in galardin-treated wild-type mice, but also in galardin-treated plg-deficient mice, suggesting that neither of the plasminogen activator and MMP systems is essential for CL formation. Nevertheless, in plg-deficient mice, serum progesterone levels were reduced by approximately 50%, and the progesterone levels were not reduced further by galardin treatment. When CL from plg-deficient mice were stained for several molecular markers for CL development and regression, they appeared healthy and vascularized, and were indistinguishable from CL from wild-type mice. This implies that the reduced progesterone levels were not caused by impaired CL formation. Taken together, our data suggest that neither plasmin nor MMPs, alone or in combination, are required for CL formation. Therefore, the tissue remodeling and angiogenesis processes during CL formation may be mediated by redundant protease systems. However, the reduced serum progesterone levels in plg-deficient mice suggest that plasmin, but not MMPs, plays a role in maintenance of luteal function. This role may be performed through proteolytic activation of growth factors and other paracrine factors.
Subject(s)
Corpus Luteum/drug effects , Corpus Luteum/physiology , Matrix Metalloproteinase Inhibitors , Plasminogen/genetics , Animals , Corpus Luteum/blood supply , Dipeptides/pharmacology , Female , Gonadotropins/pharmacology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Progesterone/blood , Pseudopregnancy/bloodABSTRACT
A decline in circulating progesterone concentration plays an important role in the ethiopathogenesis of pseudopregnancy in the bitch. Because growth hormone (GH) and prolactin (PRL) are essential for normal mammogenesis and the secretion of these hormones is influenced by changes in the circulating progesterone concentration, the purpose of this study was to investigate the effects of mid-luteal phase ovariectomy on the 6-h pulsatile plasma profiles of GH and PRL and the basal plasma concentrations of GH, PRL, and insulin-like growth factor-I (IGF-I) in six beagle bitches. Ovariectomy was followed by only mild or covert signs of pseudopregnancy. The sharp decrease of the plasma progesterone concentration was accompanied by decreased basal plasma concentrations of GH and IGF-I and a rise in basal plasma PRL concentration. GH and PRL were secreted in a pulsatile fashion both prior to and after ovariectomy. The mean basal plasma GH concentration was significantly higher before ovariectomy than on days 1 and 7 after ovariectomy. The mean area under the curve above the zero level (AUC(0)) for GH was significantly higher before than at 7 days after ovariectomy. The mean area under the curve above basal level (AUC(b)) and the frequency of GH pulses at 7 days after ovariectomy were significantly higher than before and 1 day after ovariectomy. Both the mean basal plasma PRL concentration and the mean AUC(0) for PRL increased after ovariectomy. In conclusion, ovariectomy of bitches in the mid-luteal phase stops progesterone-induced GH release from the mammary gland, as evidenced by the lowering of basal plasma GH levels, the recurrence of GH pulsatility, and the lowering of circulating IGF-I levels. The sudden lowering of plasma progesterone concentration is probably a primary cause of a prolonged increase in PRL secretion. These observations underscore the importance of similar, albeit less abrupt, hormonal changes in the cyclical physiological alterations in the mammary gland and in the development of pseudopregnancy.
Subject(s)
Dogs/physiology , Growth Hormone/metabolism , Insulin-Like Growth Factor I/metabolism , Luteal Phase/physiology , Ovariectomy/veterinary , Prolactin/metabolism , Animals , Area Under Curve , Female , Growth Hormone/blood , Progesterone/blood , Prolactin/blood , Pseudopregnancy/blood , Pseudopregnancy/veterinary , Pulsatile Flow , Secretory Rate , Time FactorsABSTRACT
During pregnancy, the lumenal diameter and wall mass of the uterine artery (UA) increase, most likely in response to the increased hemodynamic strain resulting from the chronically elevated uterine blood flow (UBF). In this remodeling process, the phenotype of vascular smooth-muscle cells (VSMC) is transiently altered to enable VSMC proliferation. These phenomena are already seen during early pregnancy, when the rise in UBF is still modest. This raises the question whether the newly instituted endocrine environment of pregnancy is involved in the onset of the pregnancy-related UA remodeling. We tested the hypothesis that the conceptus is not essential for the onset of UA remodeling of pregnancy. Six control and 18 pseudopregnant (Postcopulation Days 5, 11, and 17; n = 6 per subgroup) C57Bl/6 mice were killed and UAs were dissected and processed for either morphometric analysis or immunohistochemistry. The latter consisted of staining UA cross sections for the differentiation markers smooth muscle alpha-actin and smoothelin, and for the proliferation marker MKI67. We analyzed the UA changes in response to pseudopregnancy by ANOVA. Data are presented as mean +/- SD. By Day 11 of pseudopregnancy, the UA lumen was 25% wider and the media cross-sectional area 71% larger than in control mice. These differences were accompanied by reduced smoothelin expression and increased proliferation of UA medial VSMC. All UA morphological differences had returned or were in the process of returning to baseline values by Day 17 of pseudopregnancy. The structural and cellular aspects of UA remodeling as seen at midpregnancy are also seen in pseudopregnancy. These results support the concept that the conceptus does not contribute to the initiation of UA remodeling. We suggest that ovarian hormones trigger the onset of UA remodeling.
Subject(s)
Arteries/physiology , Pregnancy , Pseudopregnancy/physiopathology , Uterus/blood supply , Actins/metabolism , Animals , Arteries/anatomy & histology , Cytoskeletal Proteins/metabolism , Female , Mice , Mice, Inbred C57BL , Muscle Proteins/metabolism , Muscle, Smooth, Vascular/cytology , Pseudopregnancy/bloodABSTRACT
BACKGROUND: In the rat, the maintenance of gestation is dependent on progesterone production from the corpora lutea (CL), which are under the control of pituitary, decidual and placental hormones. The luteal metabolism of progesterone during gestation has been amply studied. However, the regulation of progesterone synthesis and degradation during pseudopregnancy (PSP), in which the CL are mainly under the control of pituitary prolactin (PRL), is not well known. The objectives of this investigation were: i) to study the luteal metabolism of progesterone during PSP by measuring the activities of the enzymes 3beta-hydroxysteroid dehydrogenase (3betaHSD), involved in progesterone biosynthesis, and that of 20alpha-hydroxysteroid dehydrogenase (20alphaHSD), involved in progesterone catabolism; and ii) to determine the role of decidualization on progesterone metabolism in PSP. METHODS: PSP was induced mechanically at 10:00 h on the estrus of 4-day cycling Wistar rats, and the stimulus for decidualization was provided by scratching the uterus on day 4 of PSP. 3betaHSD and 20alphaHSD activities were measured in the CL isolated from ovaries of PSP rats using a spectrophotometric method. Serum concentrations of progesterone, PRL, androstenedione, and estradiol were measured by radioimmunoassay (RIA). RESULTS: The PSP stage induced mechanically in cycling rats lasted 11.3 +/- 0.09 days (n = 14). Serum progesterone concentration was high until day 10 of PSP, and declined thereafter. Serum PRL concentration was high on the first days of PSP but decreased significantly from days 6 to 9, having minimal values on days 10 and 11. Luteal 3betaHSD activities were elevated until day 6 of PSP, after which they progressively declined, reaching minimal values at the end of PSP. Luteal 20alphaHSD activities were very low until day 9, but abruptly increased at the end of PSP. When the deciduoma was induced by scratching the uterus of pseudopregnant animals on day 4 (PSP+D), PSP was extended to 18 +/- 2.2 days (n = 8). In PSP + D rats, serum progesterone and PRL levels, and luteal 3betaHSD activities were higher than in pseudopregnant rats on day 11. Decidualization also prevented the increase in luteal 20alphaHSD activities observed on day 11 of PSP. Administration of the dopaminergic agonist CB154 in PSP + D rats on day 10 of PSP induced a decline in both serum PRL and progesterone on day 11 of PSP, values that were not different from that of pseudopregnant controls. CONCLUSIONS: We have established that during the final period of PSP a decline in progesterone biosynthesis occurs before the increase in progesterone catabolism. We have also shown that decidualization in pseudopregnant rats extends the life of the CL by prolonging the production of pituitary PRL, and by maintaining high 3betaHSD and low 20alphaHSD activities within the CL leading to sustained production of progesterone.
Subject(s)
17-Hydroxysteroid Dehydrogenases/metabolism , 20-Hydroxysteroid Dehydrogenases/metabolism , Corpus Luteum/enzymology , Deciduoma/physiology , Pseudopregnancy/enzymology , 17-Hydroxysteroid Dehydrogenases/blood , 20-Hydroxysteroid Dehydrogenases/blood , Androstenedione/blood , Animals , Bromocriptine/pharmacology , Dopamine/metabolism , Estradiol/blood , Female , Luteal Phase/blood , Luteal Phase/physiology , Progesterone/biosynthesis , Progesterone/blood , Prolactin/biosynthesis , Prolactin/blood , Pseudopregnancy/blood , Rats , Rats, WistarABSTRACT
In the estrous female rat, mating stimulation induces an acute surge of prolactin (PRL) within 20 min after mating followed by the onset of twice-daily PRL surges which persist for an 8- to 13-day period of acyclicity called pseudopregnancy. In Experiment 1, we examined whether the release of adrenal hormones after mating modulates mating-induced PRL secretion during the first 38 h after mating. Ovariectomized females were adrenalectomized (Adx) or sham-operated (Sham) and were implanted with jugular vein catheters 2 days later. They were given estrogen and progesterone and mated 6 days after the last surgery until they received 15 intromissions or 15 mounts-without-intromission from a male. Blood samples were collected beginning 20 min before mating at 23:00 h and continuing for 38 h. Plasma PRL concentrations were measured using radioimmunoassay. Mating that included intromissions induced an acute (20-min) PRL response which was higher in Adx than in Sham animals, and advanced in the Adx animals in the onset of the first daily PRL surge to 10:00 h, some 18 h before the surge was observed at 04:00 h in the Sham-mated animals. A small but measurable nocturnal surge was observed in Adx and Sham groups 18-24 h later at 04:00-10:00 h. In Experiment 2, Adx- and Sham-cycling animals received 5 (5I) or 7 (7I) intromissions from a male 12-16 days after surgery. Adx animals receiving 5I showed a significantly higher incidence of pregnancy or pseudopregnancy (%P/PSP) than did Sham 5I animals, while there was no difference in %P/PSP in the 7I groups. We conclude that adrenal gland secretions normally suppress plasma PRL concentrations immediately post-mating and before the onset of the nocturnal mating-induced PRL surge and also inhibit pseudopregnancy when females receive a subthreshold number of intromissions normally required for its induction.
Subject(s)
Adrenal Glands/metabolism , Prolactin/blood , Pseudopregnancy/blood , Sexual Behavior, Animal/physiology , Adrenalectomy , Analysis of Variance , Animals , Female , Physical Stimulation , Prolactin/metabolism , Rats , Rats, Long-EvansABSTRACT
In our previous study, dibutyltin dichloride (DBTCl) caused preimplantation embryonic loss and postimplantation embryonic loss in rats following administration at 7.6 mg/kg and above on Days 0-3 and at 3.8 mg/kg and above on Days 4-7 of pregnancy, respectively. This study was designed to assess the effects of DBTCl on uterine function as a cause of early embryonic loss using pseudopregnant rats. DBTCl was given orally to pseudopregnant rats at 3.8, 7.6 or 15.2 mg/kg on pseudopregnant day (PPD) 0-3 or on PPD 4-7. The decidual cell response was induced by bilateral uterine scratch on PPD 4. The uterine weight on PPD 9 served as an index of uterine decidualization. Uterine weight and serum progesterone levels on PPD 9 were significantly decreased after administration of DBTCl at 7.6 mg/kg and above on PPD 0-3 and PPD 4-7. DBTCl had no effect on the serum estradiol levels and number of corpora lutea. Administration of progesterone reversed the suppression of uterine decidualization in rats given DBTCl on PPD 0-3. It can be concluded that DBTCl suppresses the uterine decidual cell response and decreases progesterone levels, and these effects are responsible for early embryonic loss due to DBTCl exposure.
Subject(s)
Decidua/drug effects , Embryo Loss/etiology , Organotin Compounds/toxicity , Animals , Body Weight/drug effects , Decidua/pathology , Dose-Response Relationship, Drug , Eating/drug effects , Embryo Loss/chemically induced , Female , Gestational Age , Intubation, Gastrointestinal , Organ Size/drug effects , Organotin Compounds/administration & dosage , Progesterone/blood , Pseudopregnancy/blood , Rats , Rats, WistarABSTRACT
The aim of this study was to determine whether American Black Bears (Ursus americanus) can experience a pseudopregnancy of the same duration as pregnancy. To do this, we treated three nonmated, captive female bears with human chorionic gonadotropin (hCG) during one breeding season, and saline during another. Progesterone concentrations were measured in monthly blood samples to determine whether pseudopregnancy had occurred. Elevated progesterone concentrations were observed in two out of three bears treated with hCG. We conclude that 1) Elevated progesterone concentrations can be induced in black bears by injection of 35 U/kg hCG during the mating season. 2) Bears can experience a pseudopregnancy, identical in length to pregnancy, in which progesterone profiles are indistinguishable from those of pregnancy.
Subject(s)
Estrous Cycle/blood , Progesterone/blood , Pseudopregnancy/blood , Ursidae/blood , Animals , Chorionic Gonadotropin , Female , Pseudopregnancy/chemically inducedABSTRACT
We examined changes in the concentrations of serum progesterone (P4), estradiol-17beta (E2), FSH, LH, prolactin (PRL), and inhibin to determine their interaction and their effect on the reproductive endocrine controls of pregnant and nonpregnant female Japanese black bears. Fourteen female bears were used in this study over a 2-yr period. In the first year, six of the bears were divided into two groups; a pseudopregnant group and a nonpregnant group. In the second year, the remaining eight bears were also divided into two groups; a pregnant group and a nonpregnant group. Pregnant and pseudopregnant bears had similar P4 trends with both groups exhibiting a significant increase in December, which is the suspected time of implantation in pregnant bears. These trends correlated with an increase in PRL levels, whereas low levels of LH were maintained throughout the year. Nonpregnant bears maintained low concentrations of P4, and compared with pregnant and pseudopregnant bears, they also exhibited a delayed elevation in PRL. Luteinizing hormone activity varied among individual animals, but regardless of reproductive status, fluctuation patterns of E2, FSH, and inhibin did not differ among bears. Our results suggest that PRL may play a luteotropic role in both pregnant and pseudopregnant bears, and is possibly responsible for inducing reactivation of the dormant corpus luteum that precedes implantation in the Japanese black bear.
Subject(s)
Gonadal Steroid Hormones/blood , Gonadotropins, Pituitary/blood , Inhibins/blood , Prolactin/blood , Ursidae/blood , Animals , Estradiol/blood , Female , Follicle Stimulating Hormone/blood , Luteinizing Hormone/blood , Pregnancy , Progesterone/blood , Pseudopregnancy/blood , SeasonsABSTRACT
PURPOSE: Perimenstrual catamenial epilepsy may in part be due to withdrawal of the endogenous progesterone-derived neurosteroid allopregnanolone that potentiates gamma-aminobutyric acidA (GABA(A)) receptor-mediated inhibition. Here we sought to determine whether the anticonvulsant potencies of neuroactive steroids, benzodiazepines, phenobarbital (PB), and valproate (VPA) are altered during the heightened seizure susceptibility accompanying neurosteroid withdrawal in a rat model of perimenstrual catamenial epilepsy. METHODS: Test drugs were evaluated for their ability to alter the convulsant activity of pentylenetetrazol (PTZ) in young adult female rats, in pseudopregnant rats with prolonged exposure to high levels of progesterone (and its neurosteroid metabolites), and in pseudopregnant rats 24 h after acute withdrawal of neurosteroids by treatment with the 5alpha-reductase inhibitor finasteride. Test drugs were administered at doses equivalent to twice their ED50 values for protection against PTZ-induced clonic seizures in naive young adult female rats. RESULTS: The anticonvulsant activity of allopregnanolone (5 mg/kg, s.c.), pregnanolone (5 mg/kg, s.c.), allotetrahydrodeoxycorticosterone (15 mg/kg, s.c.), and tetrahydrodeoxycorticosterone (10 mg/kg, s.c.) were enhanced by 34-127% after neurosteroid withdrawal. The anticonvulsant activity of PB (65 mg/kg, i.p.) was also enhanced by 24% in neurosteroid-withdrawn animals. In contrast, the anticonvulsant activity of diazepam (4 mg/kg, i.p.), bretazenil (0.106 mg/kg, i.p.), and VPA (560 mg/kg, i.p.) were reduced or unchanged in neurosteroid-withdrawn animals. CONCLUSIONS: The anticonvulsant activity of neuroactive steroids is potentiated after neurosteroid withdrawal, supporting the use of such agents in the treatment of perimenstrual catamenial epilepsy.
Subject(s)
Anticonvulsants/pharmacology , Desoxycorticosterone/analogs & derivatives , Disease Models, Animal , Epilepsy/prevention & control , Menstrual Cycle/physiology , Pregnanolone/blood , Pregnanolone/pharmacology , Steroids/pharmacology , Substance Withdrawal Syndrome/prevention & control , Allosteric Regulation/drug effects , Animals , Anticonvulsants/blood , Anticonvulsants/therapeutic use , Benzodiazepinones/pharmacology , Benzodiazepinones/therapeutic use , Desoxycorticosterone/pharmacology , Diazepam/pharmacology , Diazepam/therapeutic use , Dose-Response Relationship, Drug , Epilepsy/chemically induced , Epilepsy/drug therapy , Female , Pentylenetetrazole/pharmacology , Phenobarbital/pharmacology , Phenobarbital/therapeutic use , Pregnanolone/therapeutic use , Pseudopregnancy/blood , Rats , Rats, Sprague-Dawley , Receptors, GABA/drug effects , Receptors, GABA/physiology , Steroids/blood , Steroids/therapeutic use , Substance Withdrawal Syndrome/blood , Valproic Acid/pharmacology , Valproic Acid/therapeutic useABSTRACT
PURPOSE: Perimenstrual catamenial epilepsy, the increase in seizure frequency that some women with epilepsy experience near the time of menstruation, may in part be related to withdrawal of the progesterone metabolite allopregnanolone, an endogenous anticonvulsant neurosteroid that is a potent positive allosteric gamma-aminobutyric acidA (GABA(A)) receptor modulator. The objective of this study was to develop an animal model of perimenstrual catamenial epilepsy for use in evaluating drug-treatment strategies. METHODS: A state of prolonged high serum progesterone (pseudopregnancy) was induced in 26-day-old female rats by sequential injection of pregnant mares' serum gonadotropin and human chorionic gonadotropin. Neurosteroid withdrawal was induced by treatment with finasteride (100 mg/kg, i.p.), a 5alpha-reductase inhibitor that blocks the conversion of progesterone to allopregnanolone. Plasma progesterone and allopregnanolone levels were measured by gas chromatography/electron capture negative chemical ionization mass spectrometry. Seizure susceptibility was evaluated with the convulsant pentylenetetrazol (PTZ). RESULTS: Plasma allopregnanolone levels were markedly increased during pseudopregnancy (peak level, 55.1 vs. control diestrous level, 9.3 ng/mL) and were reduced by 86% 24 h after finasteride treatment (6.4 ng/mL). Progesterone levels were unaffected by finasteride. After finasteride-induced withdrawal, rats showed increased susceptibility to PTZ seizures. There was a significant increase in the number of animals exhibiting clonic seizures when challenged with subcutaneous PTZ (60 mg/kg) compared with control pseudopregnant animals not undergoing withdrawal and nonpseudopregnant diestrous females. The CD50 (50% convulsant dose) was 46 mg/kg, compared with 73 mg/kg in nonwithdrawn pseudopregnant animals and 60 mg/kg in diestrous controls. The threshold doses for induction of various seizure signs, measured by constant intravenous infusion of PTZ, were reduced by 30-35% in neurosteroid-withdrawing animals compared with control diestrous females. No change in threshold was observed in pseudopregnant rats treated from days 7 to 11 with finasteride, demonstrating that high levels of progesterone alone do not alter seizure reactivity. CONCLUSIONS: Neurosteroid withdrawal in pseudopregnant rats results in enhanced seizure susceptibility, providing an animal model of perimenstrual catamenial epilepsy that can be used for the evaluation of new therapeutic approaches.
Subject(s)
Epilepsy/epidemiology , Menstrual Cycle/physiology , Pseudopregnancy/chemically induced , Steroids/adverse effects , Substance Withdrawal Syndrome/epidemiology , 20-alpha-Dihydroprogesterone/adverse effects , 20-alpha-Dihydroprogesterone/pharmacology , Adult , Animals , Behavior, Animal/drug effects , Disease Models, Animal , Disease Susceptibility/blood , Disease Susceptibility/epidemiology , Epilepsy/blood , Epilepsy/diagnosis , Female , Finasteride/pharmacology , Gonadotropins, Equine/blood , Gonadotropins, Equine/pharmacology , Humans , Pentylenetetrazole/pharmacology , Pregnanolone/blood , Pregnanolone/pharmacology , Progesterone/adverse effects , Progesterone/blood , Progesterone/pharmacology , Pseudopregnancy/blood , Pseudopregnancy/epidemiology , Rats , Rats, Sprague-Dawley , Receptors, GABA/blood , Receptors, GABA/drug effects , Steroids/blood , Steroids/pharmacology , Substance Withdrawal Syndrome/etiologyABSTRACT
Different molecular forms of circulating prolactin (PRL) are known to occur in several species. As no such information was available in dogs, we assessed the molecular profile of circulating PRL in bitches. Pooled sera from covertly (CTRL) and overtly pseudopregnant (PSPT) diestrous bitches with high or low (> 10 or < 10 ng x mL(-1), respectively) serum PRL (measured by ELISA) were analyzed by Sephadex G-100 and Concanavalin A-Sepharose column chromatography. Four serum PRL fractions were identified and termed big-big, big (> 67 kDa), native (23 kDa) and fragmented (< 20) kDa) PRL. The percentages of these fractions were roughly similar in CTRL and PSPT animals, irrespective of their serum PRL levels (higher in PSPT than in CTRL bitches). A large proportion of glycosylated PRL (between 69 and 100%) was also detected in these sera. We conclude that in dogs, circulating PRL occurs in multiple molecular forms, whose relative abundance is comparable in covertly and overtly pseudopregnant bitches.
Subject(s)
Dogs/blood , Prolactin/blood , Pseudopregnancy/veterinary , Animals , Chromatography, Gel/veterinary , Diestrus/blood , Dogs/physiology , Enzyme-Linked Immunosorbent Assay/veterinary , Female , Glycosylation , Prolactin/chemistry , Pseudopregnancy/bloodABSTRACT
AIM: To observe the effect of artesunate on content of progesterone, estrogen and decidua of pregnant rats and study the efficacy and mechanism of artesunate for termination of early pregnancy. METHODS: Serum content of progesterone, estrogen and TNF-alpha were measured with RIA. The effects of artesunate on the ovary, decidua and fetus of pregnant rats were studied using histochemistry techniques. Decidual cells were estimated using cell culture. RESULTS: Artesunate 40 mg.kg-1 s.c. on day 6-10 of gestation significantly decreased the concentration of serum progesterone in early pregnant rats; decidual cells and fetus of treated groups were found to be degenerated at d 11. Artesunate was shown to directly damage the decidual cells. Cultured human decidual cells were exposed to artesunate for 48 h, the LC50 was found to be 25 +/- 3 mL.L-1. CONCLUSION: The damage of artesunate on decidua and placenta may be the mechanisms of its contragestational action.
Subject(s)
Abortifacient Agents/pharmacology , Artemisinins/pharmacology , Decidua/drug effects , Estrogens/blood , Progesterone/blood , Sesquiterpenes/pharmacology , Animals , Artesunate , Cells, Cultured , Decidua/cytology , Female , Humans , Male , Pregnancy , Pseudopregnancy/blood , Rats , Tumor Necrosis Factor-alpha/metabolismABSTRACT
Reproductive dysfunction in the female diabetic rat is associated with impaired hypothalamic-hypophyseal system, anovulation, insufficiency of ovarian steroidogenesis and spontaneous failure of pregnancy. Formation of decidua, the highly modified endometrium of pregnancy and pseudopregnancy could only be achieved when the uterus was sensitized by a sequence of oestrogen and progesterone. In this study, we examined whether the impaired expression of endometrial decidualization in the pseudopregnant rat is linked with diabetes-associated hypersecretion of testosterone. Rats were made pseudopregnant by sterile mating. Diabetes was induced by streptozotocin on day 1 p.c. Deciduogenic stimulus was given on day 5 p.c. Treatment of cyproterone acetate (10 mg kg(-1)) was scheduled from day 5 through day 9 p.c. Animals were killed on day 10 p.c, and the degree of endometrial decidual growth, plasma levels of oestradiol, progesterone, ACTH and testosterone were determined. Results showed that compared to controls there was a concomitant drop in endometrial decidual growth concurrently with impaired levels of oestradiol and progesterone in diabetic pseudopregnant rats. ACTH and testosterone levels were, however, profoundly elevated. Cyproterone acetate treatment in the diabetic pseudopregnant rat resulted in a simultaneous elevation of oestradiol and progesterone, which eventually helped the endometrial differentiation to decidua in the diabetic pseudopregnant rat parallel to controls. Present experimental data suggest that diabetes-associated impaired endometrial decidualization in the pseudopregnant rat is possibly caused by testosterone-induced oestrogen deficiency.